Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1137
Title: Molecular mechanism and herb drug interaction of hydro-alcoholic extract of Terminalia arjuna bark and its ayurvedic formulations in metabolic syndrome
Authors: Mr.Sushant A.Shengule
Keywords: Terminalia arjuna; metabolic syndrome; Arjunarishta; Arjun Ghritah; herb-drug interactions; molecular mechanism; obesity; diabetes mellitus; dyslipidemia; metformin
Issue Date: 2020
Publisher: KLE Academy of Higher Education and Research, Belagavi
Abstract: ABSTRACT : Disorders like obesity, diabetes mellitus (DM), dyslipidemia and hypertension are grouped under metabolic syndrome (MS) with complex etiology, multifactorial pathogenesis and require prophylactic and therapeutic interventions. In our traditional knowledge and Indian civilizations, different herbal medicines have been advocated for DM. It is notable that Terminalia arjuna (TA) utilized in dyslipidemia, hyperglycemia, malignancy, high blood pressure and hypercholesterolemia. Arjunarishta (AA) and Arjun Ghritah (AG) are hydroalcoholic and ghee based formulation of TA respectively. These ayurvedic medicines were used to treat a lipid and cardiovascular disorders. Herbs are taken with the belief that they are helpful and safe in reducing side and adverse effects of prescription drugs. This leads to increased incidences of herb-drug interactions (HDIs). As adequate gaps present in the literature about the molecular mechanism, and HDIs, more research study in this direction is required to cover the essential issues. Objectives: The objective of the study was to assess the molecular mechanism and HDI of hydro alcoholic TA extract (TAHA) of bark and its ayurvedic formulations in MS
URI: http://localhost:8080/xmlui/handle/123456789/1137
Appears in Collections:Faculty of Pharmacy

Files in This Item:
File Description SizeFormat 
Mr.Sushant A.Shengule_2020_Faculty of Pharmacy_.pdf18.85 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.